25th World Congress on Pediatric Oncology and Cancer Care

The "25th World Congress on Pediatric Oncology and Cancer Care" is scheduled to be held in Paris , France from September 19-20, 2024, with a focus on the theme "Pediatric Cancer and Oncology: Improving Treatments and Fostering Supports." The event will encompass keynote speeches, poster presentations, oral lectures, and exhibitions, creating a comprehensive platform for discussion and learning on diverse topics related to cancer, such as Cancer Biomarkers, Anti-Cancer drug discovery therapy, Gynaecologic Oncology, Immuno Oncology, Neuro Oncology, Oncology Nursing, Pediatric Oncology, Pulmonary Oncology, Surgical Oncology, Cancer and Oncology Genetics, among others. The Pediatric Cancer Congress stands as a global platform, initiated by Conference Series, bringing together experts from both industry and academia

The conference offers an opportunity for young researchers and students to explore the presented research on pediatric cancer across various scientific disciplines. The overarching aim of Pediatric Cancer Congress 2024 is to disseminate essential knowledge in the medical and life sciences, vital for researchers in their respective fields. Given this objective, Germany is chosen as the ideal location for the exchange of information.

Pediatric Cancer Congress 2024 serves as a global forum for the presentation of cutting-edge research methodologies, innovative devices, and newly introduced drugs for pediatric and neonatal oncology. By fostering discussions on diverse topics within this domain, the conference contributes to knowledge dissemination and aims to reduce the global incidence rate of pediatric cancer. Each conference features several expert speakers, addressing various oncology-related subjects. The daily schedule of the Pediatric Oncology Congress includes numerous topic analyses, allowing participants to choose their preferred topics from the global events.

One of the key objectives of Pediatric Cancer Congress 2024 is to honor deserving young researchers, scientists, investigators, post-graduate students, post-doctoral fellows, trainees, and junior professors for their outstanding contributions to the conference theme. The Young Scientist Awards are designed to provide early-career academicians with a valuable professional development opportunity by facilitating the exchange of expertise on all aspects of cancer care and oncology.

For the 2024 nominations, the Pediatric Cancer Congress is organizing the Young Researcher Forum, which will only accept 20 presentations for Outstanding Masters/Ph.D./Post Doctorate thesis work. Participants in the Young Scientist Award category will receive certificates of achievement and souvenirs. The conference offers an excellent venue for the oral presentation of research, providing opportunities for networking, collaboration, and exposure to new technologies and employment opportunities. Additionally, the event serves as a valuable platform for young researchers to expand their knowledge across different study fields through interactions with renowned senior researchers from around the globe, particularly in the field of nanotechnology.

why to attend

The Pediatrics congress 2024 represents a unique and exciting interdisciplinary opportunity that provides a broad opportunity to showcase cutting-edge technologies, new products and services tailored to a broad global audience in the field. Participants will take advantage of an excellent opportunity to showcase the latest advances in pediatric cancer and oncology while providing comprehensive coverage of a wide range of topics. 
 

Expected to attract over 200 participants from around the world, the 2024 Pediatric Cancer Congress  promises to feature thought-provoking keynote lectures, oral presentations and poster sessions  from global experts in  medicine, health care and oncology. Delegates will include members of the editorial boards of relevant international publications. 
 

 A cost-effective marketing strategy for increasing sales, opportunities and contacts, business networking provides suppliers with a unique opportunity to connect with “leading scientists and peers.” The conference actively encourages participation from students and recent graduates through a special student poster contest and encourages the exhibition of unique research for publication in future journals. A poster session during the conference will feature all submitted abstracts. Students who are unable to physically attend may submit an electronic poster for a nominal fee of $99, which guarantees online publication of the paper with a DOI. Adding live streaming is an additional service for presenters. 
 

 Target audience: 
 

The conference is designed for a diverse audience:

•      Physicians,
•      Early career scientists,
•      Medical schools
•      Pediatric cancer societies
•      Medical device  companies,
•      Medical professionals
•      Medical directors,
•      Oncologists,
•      Medical and pharmaceutical professionals
•      Academic researchers. 
•      Postdoctoral researcher.
•      Students, researchers, managers and business representatives. 

 More than 300 participants (70% from industry, 30% from academia) 

 A lineup of over 5 keynote speakers, over 50  plenary speakers, and over 20 diverse exhibitors. 

 Over 5 masterclasses, 14 creative training sessions and business meetings. 

 The joy of attending Children's Oncology Congress 2023 lies in the opportunity to improve and progressively advance your surgical skills, as well as  gain a broader perspective through training and industry reviews.

Participant Benefits

• All programs entry
• Reception banquet
• 2 Coffee breaks and snacks during the two days
• Handbook
• Lunch during the conference
• Conference souvenir
• Abstracts will be published in our referred journal
• 25% Discount on the manuscript publication fee
• Certification by the organizing committee
• Wi-Fi facility
• CME-CPD Credits
• 50% Discount for group of 10 members
• Localities Participation Benefits:
• 20% Discount will be provided for the participants, who are attending from the local universities and hospitals.

Session / Tracks

Tracks 1  Anticancer drug-discovery therapy
Tracks 2  Cancer and Oncology Diagnosis and Screening
Tracks 3  Cancer and Oncology Genetics
Tracks 4  Cancer Awareness and Survival
Tracks 5  Cancer Biomarkers
Tracks 6  Cancer Causes and Diagnosis
Tracks 7  Cancer Management and preventions
Tracks 8  Cancer Therapeutics and Novel Approaches
Tracks 9  Colorectal Cancer and Stem Cells
Tracks 10 Epidemiology, Policy and Advocacy
Tracks 11 Epidemiology, Policy and Advocacy
Tracks 12 Gynaecologic Oncology
Tracks 13 Immuno Oncology
Tracks 14 Myeloid leukaemia, Myelodysplastic and Myeloproliferative Syndrome
Tracks 15 Neuro Oncology
Tracks 16 Oncology Nursing
Tracks 17 Organic Foods and Cancer Risk: Separating Myth from Fact
Tracks 18 Pediatric Hematologic Malignancies
Tracks 19 Proton therapy
Tracks 20 Radiation Oncology
Tracks 21 Rare tumours and Histiocytosis
Tracks 22 Rare tumours and Histiocytosis
Tracks 23 Supportive Care and Palliative Care
Tracks 24 Surgical Oncology
Tracks 25 Tumour Biology, Immunology and Immunotherapy

Others Details

Proton therapy Supportive Care and Palliative Care Tumour Biology, Immunology and Immunotherapy Pediatric Hematologic Malignancies Epidemiology, Policy and Advocacy Rare tumours and Histiocytosis